Business

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

Published On : 2026-01-14

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients.1,2 Results from the SPACE trial found AJOVY significantly reduced monthly migraine days and monthly headache days versus placebo over a 12-week period in pediatric […]

#Business

Business

Asia Loan Bankers Brace for Competition, Thinner Margins in 2026

Published On : 2026-01-14

Loan bankers in Asia are bracing for an increasingly competitive market that is squeezing the returns they earn on lending, as they grapple with subdued syndicated deal flow.

#Business


Discover more from Trend Teller

Subscribe to get the latest posts sent to your email.